M Giordano
Overview
Explore the profile of M Giordano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
482
Citations
2272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fabbroni C, Grignani G, Vincenzi B, Fumagalli E, De Pas T, Mazzocca A, et al.
ESMO Open
. 2024 Aug;
9(8):103667.
PMID: 39121815
Background: This is a multicentre, single-arm, phase II study aimed at further exploring the activity of trabectedin as second-/further-line treatment in retroperitoneal leiomyosarcoma (LMS) and well-differentiated/dedifferentiated liposarcoma (LPS). Materials And...
2.
Florio M, Careri S, Zoccali C, Aulisa A, Falciglia F, Toniolo R, et al.
Front Pediatr
. 2022 Oct;
10:970309.
PMID: 36313876
The Giant Cell tumor (GCT) is a benign, locally aggressive lesion that cause bone destruction and shows a malignant potential. It is a relatively common skeletal tumor that is therefore...
3.
Reyes-Bravo D, Villalobos-Aguilera P, Almonte-Zepeda J, Mendoza-Trejo M, Giordano M, Orozco A, et al.
Front Toxicol
. 2022 Sep;
4:933300.
PMID: 36071823
The herbicide atrazine (ATR; 2-chloro-4-ethylamino-6-isopropylamino-s-triazine) is widely used to destroy grasses and broadleaf weeds in crops and some fruits. Studies in rodents have shown that acute, repeated or chronic exposure...
4.
Boccaccino A, Borelli B, Intini R, Antista M, Bensi M, Rossini D, et al.
ESMO Open
. 2022 Jun;
7(3):100506.
PMID: 35696748
Background: Encorafenib plus cetuximab with or without binimetinib showed increased objective response rate (ORR), progression-free survival (PFS), and overall survival (OS) compared with chemotherapy plus anti-EGFR in previously treated patients...
5.
Procopio G, Chiuri V, Giordano M, Alitto A, Maisano R, Bordonaro R, et al.
ESMO Open
. 2022 Apr;
7(2):100431.
PMID: 35405438
Background: Limited real-world data exist on the effectiveness and safety of abiraterone acetate plus prednisone (abiraterone hereafter) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) naive to...
6.
DellAnnunziata F, Folliero V, Zannella C, Giordano M, Galiero R, Galdiero M
Eur Rev Med Pharmacol Sci
. 2022 Jan;
25(24):7616-7618.
PMID: 34982421
No abstract available.
7.
Licea-Haquet G, Reyes-Aguilar A, Alcauter S, Giordano M
Neuroscience
. 2021 Jul;
471:102-114.
PMID: 34332015
Pragmatic competence demands linguistic, but also communicative, social and cognitive competence. Successful use of language in social interaction requires mutual understanding of the speaker's intentions; without it, a conversation cannot...
8.
Zaed I, Bossi B, Ganau M, Tinterri B, Giordano M, Chibbaro S
Neurochirurgie
. 2021 Apr;
68(1):61-68.
PMID: 33901525
Introduction: Recent years have been characterized by a great technological and clinical development in spine surgery. In particular, enhanced recovery after surgery (ERAS) programs, started to gain interest also in...
9.
Borelli B, Fontana E, Giordano M, Antoniotti C, Lonardi S, Bergamo F, et al.
ESMO Open
. 2021 Mar;
6(2):100073.
PMID: 33676295
Introduction: The consensus molecular subtypes (CMS) demonstrated prognostic value in metastatic colorectal cancer (mCRC). Similarly, a prognostic impact was suggested for the pre-consensus CRCAssigner (CRCA) classifier in early stages. The...
10.
Chavez-Pichardo M, Reyes-Bravo D, Mendoza-Trejo M, Marin-Lopez A, Giordano M, Hernandez-Chan N, et al.
Arch Toxicol
. 2020 Jun;
94(9):3217-3230.
PMID: 32561961
Atrazine (ATR; 2-chloro-4-ethylamino-6-isopropylamino-s-triazine) is an herbicide widely used to kill annual grasses and broadleaf weeds in crops such as corn, sorghum, and sugarcane. Studies in rodents have shown that chronic...